These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28302131)

  • 1. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
    Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
    Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B; Kasapcopur O
    Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
    Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
    Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Mediterranean fever-associated infertility and underlying factors.
    Atas N; Armagan B; Bodakci E; Satis H; Sari A; Bilge NSY; Salman RB; Yardımcı GK; Babaoglu H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kasifoglu T; Kalyoncu U; Tufan A
    Clin Rheumatol; 2020 Jan; 39(1):255-261. PubMed ID: 31502094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
    Erden A; Batu ED; Sarı A; Sönmez HE; Armagan B; Demir S; Fırat E; Bilginer Y; Bilgen SA; Karadağ Ö; Kalyoncu U; Kiraz S; Ertenli I; Özen S; Akdogan A
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):97-102. PubMed ID: 30418112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial Mediterranean fever: not to be missed].
    Frenkel J; Bemelman FJ; Potter van Loon BJ; Simon A
    Ned Tijdschr Geneeskd; 2013; 157(18):A5784. PubMed ID: 23635502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based recommendations for the practical management of Familial Mediterranean Fever.
    Hentgen V; Grateau G; Kone-Paut I; Livneh A; Padeh S; Rozenbaum M; Amselem S; Gershoni-Baruch R; Touitou I; Ben-Chetrit E
    Semin Arthritis Rheum; 2013 Dec; 43(3):387-91. PubMed ID: 23742958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments.
    Ozen S; Kone-Paut I; Gül A
    Semin Arthritis Rheum; 2017 Aug; 47(1):115-120. PubMed ID: 28413100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].
    Shouval R; Livneh A; Ben-Zvi I
    Harefuah; 2015 Nov; 154(11):716-9, 741. PubMed ID: 26821505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
    Hentgen V; Vinit C; Fayand A; Georgin-Lavialle S
    Front Immunol; 2020; 11():971. PubMed ID: 32670263
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients.
    Başaran Ö; Uncu N; Çelikel BA; Taktak A; Gür G; Cakar N
    Mod Rheumatol; 2015 Jul; 25(4):621-4. PubMed ID: 25528863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
    Sönmez HE; Batu ED; Bilginer Y; Özen S
    Clin Rheumatol; 2017 Feb; 36(2):421-425. PubMed ID: 27679472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
    Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
    Sante; 2004; 14(4):261-6. PubMed ID: 15745878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G; Kose R; Senturk T
    Sao Paulo Med J; 2019 May; 137(1):39-44. PubMed ID: 31116269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for subclinical inflammation in children with Familial Mediterranean fever.
    Bayram MT; Çankaya T; Bora E; Kavukçu S; Ülgenalp A; Soylu A; Türkmen M
    Rheumatol Int; 2015 Aug; 35(8):1393-8. PubMed ID: 25669438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.